Procter & Gamble Company (The) $PG Shares Purchased by Almanack Investment Partners LLC.

Almanack Investment Partners LLC. lifted its holdings in Procter & Gamble Company (The) (NYSE:PG) by 12.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,809 shares of the company’s stock after acquiring an additional 845 shares during the quarter. Almanack Investment Partners LLC.’s holdings in Procter & Gamble were worth $1,244,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in PG. Kingstone Capital Partners Texas LLC grew its position in Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after buying an additional 76,017,350 shares during the period. Nuveen LLC acquired a new stake in Procter & Gamble during the first quarter valued at $1,954,941,000. Price T Rowe Associates Inc. MD grew its position in Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after buying an additional 2,466,308 shares during the period. Invesco Ltd. grew its position in Procter & Gamble by 19.8% during the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock valued at $2,299,580,000 after buying an additional 2,228,151 shares during the period. Finally, Valeo Financial Advisors LLC grew its position in Procter & Gamble by 1,875.5% during the second quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock valued at $280,946,000 after buying an additional 1,674,139 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

NYSE:PG opened at $149.69 on Monday. The company’s 50-day moving average price is $155.24 and its 200-day moving average price is $159.41. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The company has a market cap of $350.34 billion, a P/E ratio of 22.99, a P/E/G ratio of 3.97 and a beta of 0.36. Procter & Gamble Company has a twelve month low of $149.45 and a twelve month high of $180.43.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.06. The firm had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company’s revenue for the quarter was up 1.7% on a year-over-year basis. During the same period last year, the firm posted $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, sell-side analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Insider Transactions at Procter & Gamble

In other news, CFO Andre Schulten sold 11,638 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $1,830,308.26. Following the transaction, the chief financial officer directly owned 52,642 shares of the company’s stock, valued at approximately $8,279,007.34. This trade represents a 18.11% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, COO Shailesh Jejurikar sold 13,039 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the completion of the transaction, the chief operating officer directly owned 28,036 shares in the company, valued at approximately $4,409,221.72. This represents a 31.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 149,763 shares of company stock valued at $23,421,279. Company insiders own 0.20% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently commented on PG shares. Barclays dropped their price target on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 1st. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Procter & Gamble in a report on Wednesday, October 8th. Evercore ISI reaffirmed an “in-line” rating and set a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Wells Fargo & Company decreased their price objective on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a report on Thursday, September 25th. Finally, BNP Paribas Exane decreased their price objective on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a report on Tuesday, September 23rd. Eleven equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $172.21.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.